Renate Louw-du Toit
Renate Louw-du Toit
Post doctoral fellow, Department of Biochemistry, University of Stellenbosch
Verified email at sun.ac.za - Homepage
Title
Cited by
Cited by
Year
Potency of progestogens used in hormonal therapy: toward understanding differential actions
JP Hapgood, D Africander, R Louw, RM Ray, JM Rohwer
The Journal of steroid biochemistry and molecular biology 142, 39-47, 2014
962014
Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract
D Africander, R Louw, N Verhoog, D Noeth, JP Hapgood
Contraception 84 (4), 423-435, 2011
592011
Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy
R Louw-du Toit, MS Perkins, JP Hapgood, D Africander
Biochemical and biophysical research communications 491 (1), 140-146, 2017
372017
Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy
D Africander, R Louw, JP Hapgood
Biochemical and biophysical research communications 433 (3), 305-310, 2013
342013
Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner
R Louw-du Toit, JP Hapgood, D Africander
Journal of Biological Chemistry 289 (45), 31136-31149, 2014
322014
16α-hydroxyprogesterone: origin, biosynthesis and receptor interaction
KH Storbeck, P Swart, D Africander, R Conradie, R Louw, AC Swart
Molecular and cellular endocrinology 336 (1-2), 92-101, 2011
222011
A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-α and-β
MS Perkins, R Louw-du Toit, D Africander
The Journal of steroid biochemistry and molecular biology 174, 27-39, 2017
202017
Hormone therapy and breast cancer: emerging steroid receptor mechanisms
MS Perkins, R Louw-du Toit, D Africander
Journal of molecular endocrinology 61 (4), R133-R160, 2018
132018
Progestins used in endocrine therapy and the implications for the biosynthesis and metabolism of endogenous steroid hormones
R Louw-du Toit, KH Storbeck, M Cartwright, A Cabral, D Africander
Molecular and cellular endocrinology 441, 31-45, 2017
132017
Fourth-generation progestins inhibit 3β-hydroxysteroid dehydrogenase type 2 and modulate the biosynthesis of endogenous steroids
R Louw-du Toit, MS Perkins, JL Snoep, KH Storbeck, D Africander
PloS one 11 (10), e0164170, 2016
122016
A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptor
R Louw-du Toit, JP Hapgood, D Africander
Biochemical and biophysical research communications 526 (2), 466-471, 2020
72020
11-oxygenated estrogens are a novel class of human estrogens but do not contribute to the circulating estrogen pool
L Barnard, L Schiffer, R Louw du-Toit, JA Tamblyn, S Chen, D Africander, ...
Endocrinology 162 (3), bqaa231, 2021
62021
Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms
SB Skosana, JG Woodland, M Cartwright, K Enfield, M Komane, ...
The Journal of steroid biochemistry and molecular biology 189, 145-153, 2019
62019
The metabolic fate and receptor interaction of 16α-hydroxyprogesterone and its 5α-reduced metabolite, 16α-hydroxy-dihydroprogesterone
D van Rooyen, T du Toit, R Louw-du Toit, D Africander, P Swart, AC Swart
Molecular and cellular endocrinology 441, 86-98, 2017
62017
Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor
K Enfield, M Cartwright, R Louw-du Toit, C Avenant, D Africander, ...
Biochemical and Biophysical Research Communications 533 (4), 879-885, 2020
32020
Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception
AJ Bick, R Louw-du Toit, SB Skosana, D Africander, JP Hapgood
Pharmacology & Therapeutics, 107789, 2020
12020
Investigating the mechanism of action of hormones used in hormone replacement therapy via estrogen receptor subtypes and the influence of the progesterone receptor
MS Perkins
Stellenbosch: Stellenbosch University, 2018
12018
Progestins in menopausal hormone therapy and breast cancer risk: The debate continues
D Africander, R Louw-du Toit
Current Opinion in Endocrine and Metabolic Research, 2020
2020
The metabolic fate and receptor interaction of 16a-hydroxyprogesterone and its 5a-reduced metabolite, 16a-hydroxy-dihydroprogesterone
D van Rooyen, T du Toit, R Louw-du Toit, D Africander, P Swart, AC Swart
Molecular and Cellular Endocrinology 30, 1e13, 2016
2016
Bioidentical hormones used in Hormone Replacement Therapy: Implications for breast cancer
M Perkins, R Louw-du Toit, D Africander
The system can't perform the operation now. Try again later.
Articles 1–20